Aruna Sharma Selected Research

Ciliary Neurotrophic Factor (CNTF)

1/2021	Topical application of CNTF, GDNF and BDNF in combination attenuates blood-spinal cord barrier permeability, edema formation, hemeoxygenase-2 upregulation, and cord pathology.
3/2011	Cerebrolysin Attenuates Heat Shock Protein (HSP 72 KD) Expression in the Rat Spinal Cord Following Morphine Dependence and Withdrawal: Possible New Therapy for Pain Management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aruna Sharma Research Topics

Disease

29	Edema (Dropsy) 01/2021 - 12/2007
27	Wounds and Injuries (Trauma) 01/2021 - 12/2007
20	Brain Edema (Cerebral Edema) 01/2021 - 01/2009
14	Spinal Cord Injuries (Spinal Cord Injury) 01/2020 - 08/2009
11	Neoplasms (Cancer) 01/2021 - 01/2014
9	Craniocerebral Trauma (Head Injury) 01/2021 - 01/2014
8	Glioma (Gliomas) 01/2021 - 01/2017
7	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2020
7	Hyperthermia 01/2019 - 01/2009
7	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2012
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 10/2015
6	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2012
5	Heat Stroke (Heatstroke) 01/2021 - 09/2011
4	Stroke (Strokes) 01/2021 - 09/2011
4	Heart Arrest (Cardiac Arrest) 01/2021 - 02/2013
4	Brain Injuries (Brain Injury) 01/2020 - 01/2012
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 01/2012
2	Reperfusion Injury 01/2021 - 01/2018
2	Mental Disorders (Mental Disorder) 01/2021 - 01/2019
2	Body Weight (Weight, Body) 01/2020 - 01/2017
2	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2020
2	Sleep Deprivation 01/2020 - 01/2019
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2019 - 03/2011
2	Ischemic Stroke 01/2019 - 02/2012
2	Hypertension (High Blood Pressure) 01/2019 - 10/2013
2	Dementia (Dementias) 01/2018 - 10/2015
2	Ischemia 01/2016 - 01/2012
2	Brain Diseases (Brain Disorder) 01/2016 - 01/2012
1	Oral Ulcer (Mouth Ulcer) 01/2021
1	Cerebral Infarction 01/2021

Drug/Important Bio-Agent (IBA)

24	cerebrolysinIBA 01/2021 - 01/2010
22	Neuroprotective AgentsIBA 01/2021 - 08/2009
17	Pharmaceutical PreparationsIBA 01/2021 - 12/2007
11	Evans Blue (Blue, Evans)FDA Link 01/2021 - 12/2007
9	AntioxidantsIBA 01/2021 - 08/2009
7	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2011
5	H290-51IBA 01/2021 - 08/2009
5	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 08/2009
5	AlbuminsIBA 01/2018 - 12/2007
4	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 01/2017
4	3-n-butylphthalide (butylphthalide)IBA 01/2020 - 01/2018
4	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2009
4	Blood Proteins (Serum Proteins)IBA 01/2019 - 02/2012
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2020
3	EnzymesIBA 01/2021 - 10/2015
3	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2021 - 10/2015
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 09/2011
3	Peptides (Polypeptides)IBA 01/2021 - 09/2011
2	Pregabalin (Lyrica)FDA Link 01/2021 - 09/2011
2	Insulin (Novolin)FDA Link 01/2021 - 10/2015
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 01/2018
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 03/2011
2	MetalsIBA 01/2021 - 01/2021
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 03/2011
2	Ciliary Neurotrophic Factor (CNTF)IBA 01/2021 - 03/2011
2	Glutathione (Reduced Glutathione)IBA 01/2021 - 01/2018
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 10/2015
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2021 - 01/2017
2	ProteomeIBA 01/2021 - 01/2020
2	Amino Acids FDA Link 01/2021 - 11/2013
2	Therapeutic UsesIBA 01/2020 - 01/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2020
2	CytokinesIBA 01/2020 - 01/2020
2	ImmunosorbentsIBA 01/2020 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 01/2017
2	AntibodiesIBA 01/2019 - 01/2017
2	Nitric Oxide Synthase (NO Synthase)IBA 01/2019 - 01/2019
2	Ondansetron (Zofran)FDA LinkGeneric 01/2019 - 01/2018
2	Glial Fibrillary Acidic ProteinIBA 01/2019 - 10/2013
2	Neprilysin (Neutral Endopeptidase)IBA 01/2019 - 01/2018
2	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 03/2011
2	Amyloid beta-PeptidesIBA 01/2018 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 03/2011
2	Growth Hormone (Somatotropin)IBA 10/2015 - 06/2010
2	UbiquitinIBA 10/2015 - 10/2015
1	oxiracetamIBA 01/2021
1	anlotinibIBA 01/2021
1	Malondialdehyde (Propanedial)IBA 01/2021
1	ManganeseIBA 01/2021
1	Oxidants (Oxidizing Agents)IBA 01/2021
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021
1	Histamine H4 ReceptorsIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	beta CateninIBA 01/2021
1	bilobalideIBA 01/2021
1	cinobufotalinIBA 01/2021
1	Coloring Agents (Dyes)IBA 01/2021
1	Ginkgo biloba extract (Rokan)IBA 01/2021

Therapy/Procedure

15	Therapeutics 01/2021 - 03/2011
11	Drug Therapy (Chemotherapy) 01/2021 - 02/2012
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 01/2020
2	Cardiopulmonary Resuscitation (CPR) 01/2021 - 01/2018
2	Radiotherapy 01/2020 - 01/2020
2	Intravenous Administration 01/2018 - 01/2017
2	Induced Hyperthermia (Thermotherapy) 01/2012 - 08/2009
1	Chemoradiotherapy 01/2021
1	Resuscitation 01/2021
1	Oral Administration 01/2021
1	Induced Hypothermia 01/2021